US cannabis name Vext Science keeps Buy rating from Haywood – Cantech Letter
Gilmer’s updated analysis comes after VEXT reported its fourth quarter and year-end financial results for 2021, which Gilmer noted to be in line with expectations. We continue to build-out a vertical footprint in the Ohio market with our joint-venture partners, and will be in a position to apply for a license transfer for the dispensary […]